Clinical Trials Logo

Stenotic Coronary Lesion clinical trials

View clinical trials related to Stenotic Coronary Lesion.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03118531 Completed - Clinical trials for Coronary Artery Disease

China Resolute Integrity 34/38 mm Study

Start date: April 17, 2017
Phase: N/A
Study type: Interventional

To evaluate the clinical safety and efficacy in Chinese subjects, eligible for percutaneous transluminal coronary angioplasty (PTCA) in lesions amenable to treatment with a 34/38 mm Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System.

NCT ID: NCT01334268 Completed - Clinical trials for Coronary Artery Disease

RESOLUTE China RCT

R-China RCT
Start date: September 2011
Phase: N/A
Study type: Interventional

The primary objective of this study is to evaluate the in-stent late lumen loss (LLL) at 9 months, defined as the difference between the post-procedure minimal lumen diameter (MLD) and the follow-up angiography MLD, of the Resolute Zotarolimus-Eluting Coronary Stent System compared to Taxus Liberte Paclitaxel-Eluting Coronary Stent System in a real-world all-comer patient population requiring stent implantation.

NCT ID: NCT01243749 Completed - Clinical trials for Coronary Artery Disease

RESOLUTE China Registry:

R-C Registry
Start date: December 2010
Phase:
Study type: Observational

To document the safety and overall clinical performance of the Resolute Zotarolimus-Eluting Coronary Stent System in a real-world patient population requiring stent implantation.